tiprankstipranks
Janux Therapeutics Announces Board of Directors Reshuffle
Company Announcements

Janux Therapeutics Announces Board of Directors Reshuffle

Don't Miss our Black Friday Offers:

Janux Therapeutics Inc (JANX) has provided an update.

Janux Therapeutics, Inc. has experienced a shift in its Board of Directors, with Jay Lichter, Ph.D. stepping down and Ron Barrett, Ph.D. taking over as Chair. Additionally, Natasha Hernday and Eric Dobmeier have been appointed as new board members. Their terms will last until the annual meetings of stockholders in 2026 and 2027, respectively. Both Hernday and Dobmeier will receive a cash retainer, stock options, and restricted stock units as part of their compensation, with provisions for full vesting in the event of a company takeover. The company publicly announced these changes via a press release.

Learn more about JANX stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskJanux Therapeutics’ Q3 Report: Financials and Progress
TheFlyJanux Therapeutics price target raised to $82 from $62 at BTIG
TheFlyJanux Therapeutics reports Q3 EPS (51c), consensus (33c)
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App